Analysis of the Incidence and Severity of Cellulitis During the COVID ‐19 Pandemic in Japan
The Journal of Dermatology · 2025
DOI: 10.1111/1346-8138.17853 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Tomoyo Sato und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Cellulitis, COVID-19. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
During the COVID‐19 pandemic, a decline in various infectious disease cases was observed. However, changes in dermatological infectious diseases, particularly cellulitis, and the potential impact of delayed consultations on severe cases have not been fully explored. To investigate changes in the number of cellulitis patients and severe cases during the COVID‐19 pandemic. We employed a difference‐in‐differences (DID) design using a de‐identified claims database from 242 acute‐care hospitals across Japan to compare the pre‐pandemic period (January 1, 2015, to December 31, 2019) with the pandemic period (January 1, 2020, to December 31, 2020). The national state of emergency, declared by the Japanese government in April 2020 in response to COVID‐19, was treated as an exogenous shock. The study analyzed outpatient, inpatient, and total cases, sepsis and bacteremia complications, ambulance transport rates, length of hospital stay, and inpatient comorbidities. A total of 28 673 cellulitis cases were analyzed (24 256 from 2015 to 2019; 4417 in 2020). Severity indicators included hospitalization (8.2%), sepsis (4.1%), bacteremia (1.7%), and ambulance transport (17.0%). In the DID analysis, a significant decrease was observed in total cellulitis cases (incidence rate ratio [IRR]: 0.91; 95% confidence interval [CI]: 0.85–0.97), outpatient cases (IRR: 0.92; 95% CI: 0.86–0.98), and inpatient cases (IRR: 0.81; 95% CI: 0.66–0.99). No significant differences were found in sepsis (IRR: 0.53; 95% CI: 0.26–1.10), bacteremia (IRR: 0.73; 95% CI: 0.19–2.86), ambulance transport (IRR: 0.81; 95% CI: 0.50–1.29), or length of hospital stay (IRR: 0.83; 95% CI: 0.66–1.03). During the pandemic, the number of cellulitis cases treated in Japanese acute‐care hospitals decreased without a significant rise in severe cases, suggesting the possibility that avoidance of medical consultations may not have worsened outcomes. Pandemic‐related behavioral changes may have contributed to the reduced incidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Division of Public Health, Department of Social Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Health Care Policy, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
- Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Tomoyo Sato, Kazuhiro Abe, Hisashi Uhara
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Sato, T., Abe, K., Miyawaki, A., Ohnishi, H., & Uhara, H. (2025). Analysis of the Incidence and Severity of Cellulitis During the COVID ‐19 Pandemic in Japan. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17853
Vancouver
Sato T, Abe K, Miyawaki A, Ohnishi H, Uhara H. Analysis of the Incidence and Severity of Cellulitis During the COVID ‐19 Pandemic in Japan. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17853
BibTeX
@article{Sato2025,
author = {Sato, Tomoyo and Abe, Kazuhiro and Miyawaki, Atsushi and Ohnishi, Hirofumi and Uhara, Hisashi},
title = {Analysis of the Incidence and Severity of Cellulitis During the COVID ‐19 Pandemic in Japan},
journal = {The Journal of Dermatology},
year = {2025},
doi = {10.1111/1346-8138.17853}
}
EUVIMED